Clarity Research conducts large-scale clinical research studies across many therapeutic areas under the guidance of physicians and experts. They summarize interim results from two ongoing studies - the OPERA study on pain management suggests topical analgesics may reduce pain scores and medication use, and the TARGET study on wound/scar treatment suggests creams may reduce scar size and pain medication use. They invite physicians to become study investigators and provide information on the role, responsibilities, application process and support provided.

1. R E S E A R C H
WELCOME BOOK
Spring/Summer
2016
Effective:04/25/16 E-00058.00

4. Our Work
Clarity Research, LLC, is a leading international scientific
research organization that conducts rigorous, large-scale
research in healthcare across many therapeutic specialties.
Under the guidance of internationally recognized
physicians, research scientists, board-certified healthcare
attorneys, and expert statisticians, our institutional review
board (IRB)-approved clinical studies are producing
reliable, informative results. Our research is well-received
by healthcare providers and continues to be recognized
by major national and international conferences.
We are committed to strategically growing our Company
through constant improvement of our approach, capabilities,
and operations, and by identifying opportunities to strengthen
our global footprint and reputation.
Welcome!

5.  Chronic Pain
 Diabetes
 Depression/Mental Health
 Pharmacogenetics
 GERD
 Allergies
 Immunotherapy
 Chronic Sinusitis
 Oncology
 Scar & Burn
Our Values
Our goal is to conduct scientifically rigorous and valid research that advances innovation in science and ultimately
helps healthcare professionals provide improved patient care, leading to improved patient health worldwide.
Whether through improving treatment methodologies or identifying new ones, we aspire to make a global positive
impact on patient health and to improve quality of life for patients and their families.
 Dermatology
 Women’s Health
 Rheumatoid Arthritis
Areas of Research
We develop and conduct clinical observational research studies around the globe in many key therapeutic
areas, including:

6. We invite you to become a Study Investigator, to assist us as we conduct
important research around the globe across multiple specialities.
Opportunity
Become A Study Investigator
For more information, call: 1-800-616-9403.
To apply online, visit www.clarityscience.com.
All necessary documentation and training is
provided to you and your staff.
Applying is easy.
You may be able to help your valued patients
achieve better health.
Our research studies are easily integrated
into your practice.

8. Our Study Investigators are a valuable and integral part of our research.
We continually invite a select number of busy, successful practitioners to become Study Investigators and to participate
in our IRB-approved, clinical observational studies. As a Study Investigator, you have an opportunity to:
Opportunity
Study Investigator
Evaluate your patients’ use
of innovative treatment.
Be a part of groundbreaking, global
research that may influence healthcare
and ultimately help patients worldwide.
If selected, you are compensated for your time and services in identifying and enrolling patients in the study and for the
collection and submission of data during the study period.


9. How Will Being a Study Investigator Affect My Practice?
We understand your time is valuable. That’s why we’ve designed our clinical observational studies
to work efficiently as part of your busy practice.
We supply you with all the necessary study documentation, as well as 2-3 days of comprehensive
in-office training with a trained Clarity Implementation Specialist.
We offer an efficient and compliant electronic submission of patient surveys, which ensures data
accuracy and convenience for you.
We provide a dedicated Account Manager, who is available to you for the duration of the study
when you have questions or need assistance.
We provide compensation for your participation and time enrolling patients in the study and
collecting and submitting data during the study period.





10. With the help of our Study Investigators, our studies are producing reliable and informative results. We are
proud to be recognized and to present our study data at major national and international conferences.
Conference Presentations & Attendance
TARGET Study (Wound, Scar and Burn)
TopicAl Silicone in RestorinG Scars and Burn Tissue – Evaluating Therapy
6th SCAR Club
September 7-8, 2015
7th Joint Meeting of the European Tissue Repair Society
& the Wound Healing Society
October 21-23, 2015
The Journal of Wound Technology, Special Issue: Scar
January 2016
34th Annual Meeting of the North American Burn Society
January 16-21, 2016
15th Annual American Professional Wound Care Association
2016 National Clinical Conference*
March 31-April 2, 2016
*Awarded First Place for Best Scientific Presentation/Data

11. 3rd Annual Pain Care for Primary Care Conference
July 28-29, 2016
American Academy of Pain Management’s 27th Annual
Clinical Meeting
September 22-25, 2016
PAINWeek National Conference
September 6-10, 2016
International Association for the Study of Pain’s 2016
World Congress on Pain
September 26-30, 2016
TREAT Study (Allergy)
Transdermal Relief: Evaluating Allergy Topicals for Perennial
Allergic Rhinitis
2016 American Academy of Allergy, Asthma & Immunology
Annual Meeting
March 4-7, 2016
American College of Allergy, Asthma & Immunology
2016 Annual Scientific Meeting
November 10-14, 2016
OPERA Study (Pain)
Optimizing Patient Experience and Response to Topical Analgesics
4th Annual International Conference on Opioids at Harvard
Medical School
June 7-9, 2015
PAINWeek National Conference
September 8-12, 2015
American Academy of Pain Management’s 26th Annual
Clinical Meeting
September 17-20, 2015
Pain Society of the Carolinas 2015 Annual Meeting
October 23-25, 2015
American Academy of Pain Medicine’s 32nd Annual Meeting
February 18-21, 2016
American Pain Society’s 35th Annual Scientific Meeting
May 11-14, 2016
8th World Congress of the World Institute of Pain
May 20-23, 2016
5th Annual International Conference on Opioids at Harvard
Medical School
June 5-7, 2016

12. Study Results
Our clinical observational studies are producing reliable and positive results:
OPERA Study (Pain)
Optimizing Patient Experience and Response to Topical Analgesics
Interim data from our OPERA study suggests that the
topical/transdermal analgesics used by patients in the
study may*:
Reduce BPI severity and interference scores
for adult patients with neuropathic and
musculoskeletal pain
Reduce the number of primary pain complaints
for each of arthritis, neuropathy or radiculopathy,
myofascial/musculoskeletal pain or spasm,
and tendinitis


Reduce the use of oral OTC, anti-inflammatory
and opioid analgesics

TARGET Study (Wound, Scar and Burn)
TopicAl Silicone in RestorinG Scars and Burn Tissue – Evaluating Therapy
Interim results from our TARGET study suggest that the
scar/burn creams used by patients in the study may*:
Reduce scar/burn size (as measured by
clinicians and as perceived by patients)
Reduce itching


Reduce daily living interference scores
and improve mood

Reduce pain medication use
*Visit www.clarityscience.com/studies-outcomes for interim data.

14. Who can apply to become a Study Investigator?
Any licensed U.S. physician with an active NPI number
can apply to become a Study Investigator.
What are my responsibilities as a Study Investigator?
Study Investigators are responsible for identifying
and enrolling patients who have been prescribed a
treatment that the study protocol is observing and
evaluating. Responsibilities also include collecting and
submitting study data during the study period.
Who can be enrolled as a study participant?
Inclusion criteria for study participants varies by study.
As a Study Investigator, you will be provided with a study
protocol, where you can find full details regarding which
of your patients are eligible to participate in the study.
What is an institutional review board (IRB)?
An institutional review board (IRB) is a committee that
performs ethical review of proposed research. The U.S.
Department of Health and Human Services requires a
registered IRB to approve research before involvement
of human subjects can begin.
Will my participation as a Study Investigator interfere
with my day-to-day practice?
We understand your time is valuable, so we’ve designed
our studies to be as non-invasive to your practice
as possible. We supply all the study documentation
you will need, along with personalized training and
administrative support throughout the duration of the
study period.
FAQs

15. How long is training?
After becoming a Study Investigator, a Clarity
Implementation Specialist will travel to your location to
provide in-office training to you and your staff over 2 or
3 days. Training includes: How to conduct the study,
review of study documentation, and how to collect
and submit study data to Clarity.
How is compensation determined?
Compensation for Study Investigators is determined
based on third-party fair market value (FMV). You will be
compensated for your time and services in identifying
and enrolling patients and collecting and submitting
study data during the study period.
What happens if I have questions during the study?
As a Study Investigator, you will be assigned an Account
Manager, who will be available to you when you have
questions or need assistance during the duration of
the study.
How do I apply to become a Study Investigator?
If you are interested in becoming a Study Investigator
for one of our current or future studies, please contact
us at: 1-800-616-9403. To apply online, please visit us
at www.clarityscience.com.

16. 1-800-616-9403 | studies@crcsciences.com | www.clarityscience.com
6300 Bridge Point Parkway, Building 3, Suite 200 | Austin, TX 78730
R E S E A R C H